0001562180-23-005178.txt : 20230614
0001562180-23-005178.hdr.sgml : 20230614
20230614193000
ACCESSION NUMBER: 0001562180-23-005178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230612
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Jonathan C
CENTRAL INDEX KEY: 0001655016
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 231015697
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-262-7002
MAIL ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-12
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001655016
Fox Jonathan C
C/O 3415 COLORADO AVE
BOULDER
CO
80303
true
false
false
false
false
Stock Option (Right to Buy)
9.55
2023-06-12
4
A
false
22123.00
0.00
A
2024-06-12
2033-06-12
Common Stock
22123.00
22123.00
D
100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders.
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
2023-06-14